UNCY
Unicycive Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.638
Haut
$0.638
Bas
$0.638
Volume
4.18M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.
Unicycive Therapeutics to Present at Upcoming Investor Conferences
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.